Clinical Trial Update: Recombinant CMV gB Vaccine in Postpartum Women [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of a recombinant CMV glycoprotein B vaccine in postpartum women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Recombinant CMV gB vaccine (cytomegalovirus glycoprotein B recombinant vaccine)

Snippet

Sponsor: Robert Pass, MD | Conditions: Cytomegalovirus Infections | Phase 2 | Status: COMPLETED